Spire Healthcare Group (LON:SPI) Stock Price Down 16.9% – Should You Sell?

Spire Healthcare Group plc (LON:SPI) shares were down 16.9% during mid-day trading on Wednesday . The stock traded as low as GBX 185 and last traded at GBX 185.80. Approximately 8,659,000 shares traded hands during trading, an increase of 493% from the average daily volume of 1,461,109 shares. The stock had previously closed at GBX 223.50.

Analyst Ratings Changes

Separately, JPMorgan Chase & Co. reduced their price target on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an “overweight” rating for the company in a research report on Tuesday, August 5th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of “Buy” and an average price target of GBX 294.33.

Spire Healthcare Group Stock Performance

The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25. The stock’s fifty day simple moving average is GBX 234.27 and its 200 day simple moving average is GBX 222.02. The company has a market cap of £747.61 million, a price-to-earnings ratio of 40.39, a P/E/G ratio of 1.06 and a beta of 0.96.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.